Arcutis Biotherapeutics's market cap is currently $1.57B. The company's EPS TTM is $-1.792; its P/E ratio is ―; Arcutis Biotherapeutics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 59.61M	$ 3.69M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 54.62M	$ 2.93M	$ -763.00K	$ -455.00K	$ -195.00K
Operating Income	$ -241.10M	$ -301.63M	$ -206.53M	$ -136.65M	$ -43.13M
EBITDA	$ -227.43M	$ -294.55M	$ -205.59M	$ -135.22M	$ -41.80M
Net Income	$ -262.14M	$ -321.29M	$ -205.90M	$ -135.68M	$ -42.00M
Balance Sheet
Cash & Short-Term Investments	$ 271.86M	$ 409.59M	$ 387.06M	$ 284.44M	$ 101.27M
Total Assets	$ 341.37M	$ 449.27M	$ 408.15M	$ 298.27M	$ 107.01M
Total Debt	$ 205.92M	$ 202.54M	$ 77.56M	$ 4.96M	$ 307.00K
Net Debt	$ 117.52M	$ 148.90M	$ -18.89M	$ -60.12M	$ -63.03M
Total Liabilities	$ 252.70M	$ 239.69M	$ 110.47M	$ 27.65M	$ 172.04M
Stockholders' Equity	$ 88.67M	$ 209.58M	$ 297.68M	$ 270.62M	$ -65.03M
Cash Flow
Free Cash Flow	$ -247.49M	$ -281.00M	$ -175.62M	$ -113.35M	$ -43.13M
Operating Cash Flow	$ -247.06M	$ -257.71M	$ -174.63M	$ -113.03M	$ -42.84M
Investing Cash Flow	$ 180.23M	$ -87.20M	$ -75.95M	$ -181.82M	$ -26.32M
Financing Cash Flow	$ 101.32M	$ 301.80M	$ 281.95M	$ 298.14M	$ 93.10M

Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History

Income Statement >

Arcutis Biotherapeutics Debt to Assets

Balance Sheet >

Arcutis Biotherapeutics Cash Flow

Cash Flow >

Arcutis Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing